The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer

被引:252
作者
Scott, HR
McMillan, DC
Forrest, LM
Brown, DJF
McArdle, CS
Milroy, R
机构
[1] Univ Glasgow, Royal Infirm, Dept Surg, Glasgow G31 2ER, Lanark, Scotland
[2] Stobhill Gen Hosp, Dept Resp Med, Glasgow G21 3UW, Lanark, Scotland
关键词
non-small cell lung cancer; C-reactive protein; weight-loss; performance status; quality of life; fatigue; survival;
D O I
10.1038/sj.bjc.6600466
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relationship between the magnitude of systemic inflammatory response and the nutritional/functional parameters in patients with inoperable non-small cell lung cancer were studied. The extent of weight loss, albumin, C-reactive protein, performance status and quality of life was measured in 106 patients with inoperable non-small cell lung cancer (stages III and IV). Survival analysis was performed using the Cox proportional hazard model. The majority of patients were male and almost 80% had elevated circulating C-reactive protein concentrations (> 10 mg l(-1)). On multivariate analysis, age (P=0.0 12), tumour type (0,002), weight loss (P=0.056), C-reactive protein (P=0.047), Kannofsky performance status (P=0.002) and fatigue (P=0,046) were independent predictors of survival. The patients were grouped according to the magnitude of the C-reactive protein concentrations (less than or equal to 10, 11 - 100 and > 100 mg l(-1)). An increase in the magnitude of the systemic inflammatory response was associated with increased weight loss (P=0.004), reduced albumin concentrations (P=0.00 1), reduced performance status (P=0.060), increased fatigue (P=0.011) and reduced survival (HR 1.936 95%Cl 1.414-2.650, P<0.001). These results indicate that the majority of patients with inoperable non-small cell lung cancer have evidence of a systemic inflammatory response. Furthermore, an increase in the magnitude of the systemic inflammatory response resulted in greater weight loss, poorer performance status, more fatigue and poorer survival. (C) 2002 Cancer Research UK.
引用
收藏
页码:264 / 267
页数:4
相关论文
共 23 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Stimulation of tumour growth by wound-derived growth factors [J].
Abramovitch, R ;
Marikovsky, M ;
Meir, G ;
Neeman, M .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1392-1398
[3]   Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer [J].
Barber, MD ;
Ross, JA ;
Fearon, KCH .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1999, 35 (02) :106-110
[4]   Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients [J].
Barber, MD ;
Fearon, KCH ;
McMillan, DC ;
Slater, C ;
Ross, JA ;
Preston, T .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (03) :E707-E714
[5]  
FALCONER JS, 1995, CANCER, V75, P2077, DOI 10.1002/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO
[6]  
2-9
[7]  
Fearon K C, 2001, Surg Oncol Clin N Am, V10, P109
[8]   ELEVATED CIRCULATING INTERLEUKIN-6 IS ASSOCIATED WITH AN ACUTE-PHASE RESPONSE BUT REDUCED FIXED HEPATIC PROTEIN-SYNTHESIS IN PATIENTS WITH CANCER [J].
FEARON, KCH ;
MCMILLAN, DC ;
PRESTON, T ;
WINSTANLEY, FP ;
CRUICKSHANK, AM ;
SHENKIN, A .
ANNALS OF SURGERY, 1991, 213 (01) :26-31
[9]   Cytokine levels (IL-6 and INF-γ), acute phase response and nutritional status as prognostic factors in lung cancer [J].
Martín, F ;
Santolaria, F ;
Batista, N ;
Milena, A ;
Gonzalez-Reimers, E ;
Brito, MJ ;
Oramas, J .
CYTOKINE, 1999, 11 (01) :80-86
[10]   Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients [J].
McMillan, DC ;
Scott, HR ;
Watson, WS ;
Preston, T ;
Milroy, R ;
McArdle, CS .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1998, 31 (02) :101-105